After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...
Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...
EST Cathie Wood’s ARK Investment buys 250K shares of 10x Genomics (TXG) todayMaximize Your Portfolio with Data Driven Insights:Leverage ...
We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...
5d
Zacks.com on MSN10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseThe market expects 10x Genomics (TXG) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results